## 3 Results
\begin{table}
\begin{tabular}{c c c c c c c c c c} \hline \hline \multirow{2}{*}{**Group**} & \multirow{2}{*}{\begin{tabular}{c} **Group** \\ **Number** \\ \end{tabular} } & \multirow{2}{*}{\begin{tabular}{c} **SOD** \\ **(\(\mu\)mol/min g tissue)** \\ \end{tabular} } & \multicolumn{2}{c}{**GPO (mmol/min g**} & \multicolumn{2}{c}{**AST (mmol/min g tissue)**} & \multicolumn{2}{c}{**ALT (mmol/min g tissue)**} \\ \cline{3-10}  & & **Heart** & **Liver** & **Heart** & **Liver** & **Heart** & **Liver** & **Heart** & **Liver** \\ \hline \multirow{3}{*}{Control group} & \multirow{3}{*}{1} & 42.86\% & 32.95\% & 4.63\% & 40.92\% & 623.08\% & 267.83\% & 479.07\% & 183.41\% \\  & & (31.79\% \(\div\) & (22.44\% \(\div\) & (09\% \(\div\) & (29.92\% \(\div\) & (495.42\% \(\div\) & (202.42\% \(\div\) & (383.78\% \(\div\) & (155.75\% \(\div\) \\) & & 64.55\% ) \({}^{*}\) & 53.55\% ) \({}^{*}\) & 13.84\% \({}^{*}\) & 62.47\% \({}^{*}\) & 873.28\% \({}^{*}\) & 360.74\% \({}^{*}\) & 665.84\% \({}^{*}\) & 237.62\% \({}^{*}\) \\ \hline \multirow{3}{*}{\begin{tabular}{c} 0.9\% NaCl solution \\ \end{tabular} } & \multirow{3}{*}{2} & 32.53\% & 50.11\% & 10.26\% & 29.84\% & 463.81\% & 192.31\% & 693.37\% & 239.36\% \\  & & (22.05\% \(\div\) & (38.93\% \(\div\) & (3.47\% \(\div\) & (19.61\% \(\div\) & (371.96\% \(\div\) & (162.52\% \(\div\) & (549.49\% \(\div\) & (198.52\% \(\div\) \\) & & 53.06\% ) \({}^{*}\) & 72.03\% ) \({}^{*}\) & 23.55\% \({}^{*}\) & 49.90\% \(\div\) \({}^{*}\) & 643.84\% \({}^{*}\) & 250.70\% \(\div\) \({}^{*}\) & 974.49\% \(\div\) \({}^{*}\) & 319.41\% \({}^{*}\) \\ \hline \multirow{3}{*}{\begin{tabular}{c} Inhibitor of the enzyme gamma-butyrobetaine hydroxylase \\ \end{tabular} } & \multirow{3}{*}{3} & 116.00\% & 114.33\% & 96.40\% & 112.90\% & 119.73\% & 101.74\% & 97.64\% & 110.19\% \\  & & (106.37\% \(\div\) & (105.28\% \(\div\) & (29.23\% \(\div\) & (104.37\% \(\div\) & (108.86\% \(\div\) & (98.76\% \(\div\) & (94.24\% \(\div\) & (102.07\% \(\div\) \\) & & 134.88\% ) \({}^{*}\) & 132.07\% ) \({}^{*}\) & 104.56\% \(\div\) & 129.63\% \(\div\) & 141.03\% \(\div\) \({}^{*}\) & 107.57\% \(\div\) & 104.29\% \(\div\) \({}^{*}\) \\ \cline{1-1}  & & 12 & 12 & 12 & 12 & 12 & 12 & 12 & 12 \\ \hline \multirow{3}{*}{\
\begin{tabular}{c} Liguscium wallichi extract \\ \end{tabular} } & \multirow{3}{*}{4} & 115.56\% & \multirow{3}{*}{56.00\% \(\div\) (44.90\% \(\div\) (44.90\% \(\div\) (136.22\% \(\div\) & 266.56\% \(\div\) & 36.90\% \(\div\) & 200.15\% \(\div\) & 73.60\% \(\div\) & 76.510\% \(\div\) \\  & & 12.2\% & 77.76\% ) \({}^{*}\) & 1.2 & 1.2 & 1.3 & 1.3 & 1.3 & 1.3 \\ \hline \multirow{3}{*}{
\begin{tabular}{c} Liguscium wallichi extract \\ \end{tabular} } & \multirow{3}{*}{5} & 126.09\% & 97.30\% & 94.77\% & 104.88\% & 97.82\% & 91.09\% & 107.96\% & 100.16\% \\  & & (113.26\% \(\div\) & (93.67\% \(\div\) & (89.79\% \(\div\) & (99.82\% \(\div\) & (94.56\% \(\div\) & (84.72\% \(\div\) & (101.40\% \(\div\) \\  & & 151.22\% & 104.40\% ) & 104.53\% ) & 114.79\% ) & 104.22\% \(\div\) & 103.58\% \(\div\) \({}^{*}\) & 120.80\% \(\div\) \({}^{*}\) \\ \cline{1-1}  & & 11.24 & 12 & 12 & 12 & 12 & 12 & 12 & 12.4 \\ \hline \hline \end{tabular} Notes. Here and below \(p<0.05\); \({}^{*}\)—differences from the initial level of enzyme activity; 1–4—differences from the level of enzyme activity in animals of the corresponding group; results present as odds ratios with \(p<0.05\) interval.  
\end{table} 
Table 4: Changes in enzyme activity from baseline under conditions of chronic stress. \begin{table}
\begin{tabular}{c c c c c c c c c c} \hline \hline \multirow{2}{*}{**Group**} & \multirow{2}{*}{\ \begin{tabular}{c} **Group** \\ **Number** \\ \end{tabular}